We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $4.08B
1-Year Est. Return 58.77%
This Fund
S&P 500
This Quarter Est. Return
+19.09%
1 Year Est. Return
+58.77%
3 Year Est. Return
+143.94%
5 Year Est. Return
+167.17%
10 Year Est. Return
+536.06%
AUM
$3.27B
AUM Growth
-$5.76B
Cap. Flow
-$1.51B
Cap. Flow %
-46.09%
Top 10 Hldgs %
34.23%
Holding
5,681
New
749
Increased
1,274
Reduced
3,081
Closed
446

Sector Composition

Rank Sector Weight
1 Technology 9.66%
2 Financials 8.46%
3 Healthcare 8.24%
4 Consumer Discretionary 7.74%
5 Industrials 6.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ROOT icon
1751
Root
ROOT
$799M
$191K 0.01%
+675
New +$223K
PRMW
1752
DELISTED
Primo Water Corporation
PRMW
$190K 0.01%
12,120
-353,968
-97% -$5.22M
PFPT
1753
DELISTED
Proofpoint, Inc.
PFPT
$190K 0.01%
1,392
-659
-32% -$72.2K
AIN icon
1754
Albany International
AIN
$1.79B
$189K 0.01%
2,574
-22,278
-90% -$1.4M
FOVL
1755
DELISTED
iShares Focused Value Factor ETF
FOVL
$189K 0.01%
4,442
-5,375
-55% -$204K
GL icon
1756
Globe Life
GL
$14.1B
$189K 0.01%
1,994
-4,521
-69% -$403K
NOVA
1757
DELISTED
Sunnova Energy
NOVA
$189K 0.01%
4,185
-4,435
-51% -$154K
AMWD
1758
DELISTED
American Woodmark
AMWD
$188K 0.01%
2,009
-13,814
-87% -$1.26M
LEGN icon
1759
Legend Biotech
LEGN
$4.22B
$188K 0.01%
6,699
+6,629
+9,470% +$191K
PRK icon
1760
Park National Corp
PRK
$3.67B
$188K 0.01%
1,790
-7,218
-80% -$709K
SNY icon
1761
Sanofi
SNY
$104B
$188K 0.01%
3,875
-2,441
-39% -$120K
JBTM
1762
JBT Marel
JBTM
$6.32B
$187K 0.01%
1,640
-25,727
-94% -$2.65M
ONCT
1763
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
$187K 0.01%
1,907
+1,835
+2,549% +$116K
TREC
1764
DELISTED
Trecora Resources
TREC
$187K 0.01%
26,785
-4,578
-15% -$30.7K
DVAX
1765
DELISTED
Dynavax Technologies
DVAX
$186K 0.01%
41,920
+7,963
+23% +$36K
NRC icon
1766
NRC Health Common Stock
NRC
$473M
$186K 0.01%
4,347
-9,921
-70% -$509K
NSIT icon
1767
Insight Enterprises
NSIT
$4.43B
$186K 0.01%
2,443
-20,301
-89% -$1.37M
NXRT
1768
NexPoint Residential Trust
NXRT
$631M
$186K 0.01%
4,393
-19,329
-81% -$846K
GTHX
1769
DELISTED
G1 Therapeutics, Inc. Common Stock
GTHX
$186K 0.01%
10,340
+5,453
+112% +$81.5K
DQ
1770
Daqo New Energy
DQ
$984M
$185K 0.01%
3,223
-6,042
-65% -$263K
LAUR icon
1771
Laureate Education
LAUR
$5.05B
$185K 0.01%
12,717
-101,884
-89% -$1.44M
UCO icon
1772
ProShares Ultra Bloomberg Crude Oil
UCO
$435M
$185K 0.01%
20,424
-83,848
-80% -$633K
UIS icon
1773
Unisys
UIS
$205M
$185K 0.01%
9,389
-102,063
-92% -$1.47M
DRNA
1774
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
$185K 0.01%
8,405
+5,100
+154% +$112K
BFH icon
1775
Bread Financial
BFH
$4.36B
$184K 0.01%
3,100
-569
-16% -$28.6K

Similar funds

Tower Research Capital (TRC)'s Q4 2020 Portfolio in Review

As of Q4 2020, Tower Research Capital (TRC) held 5,681 positions worth $3.27B, down 64% from $9.03B the previous quarter. Its ten largest holdings account for 34% of the portfolio.

Tower Research Capital (TRC) withdrew a net $1.51B in Q4 2020, closing 446 positions and reducing 3,081 holdings. Its most notable exit was iShares Russell 2000 Growth ETF, an estimated $13.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 9.7% of assets, up from 6.3% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Tower Research Capital (TRC) opened a new position in iShares Russell 1000 ETF worth $24.4M.

  • Tower Research Capital (TRC)'s largest Q4 2020 buy was iShares Russell 1000 ETF: 115,321 shares worth $24.4M.
  • Tower Research Capital (TRC) added most to State Street SPDR S&P 500 ETF Trust in Q4 2020, an estimated $99.8M increase.
  • Tower Research Capital (TRC)'s biggest Q4 2020 reduction was iShares Russell 2000 ETF, cutting an estimated $36.3M.
  • Tower Research Capital (TRC) fully exited iShares Russell 2000 Growth ETF in Q4 2020, selling an estimated $13.7M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 34% of its $3.27B portfolio in Q4 2020.
  • Tower Research Capital (TRC) opened 749 new positions and closed 446 in Q4 2020.
  • Tower Research Capital (TRC)'s portfolio value fell 64% quarter-over-quarter to $3.27B.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2020, filed 16 Feb 2021.